Related Experiment Video
Updated: Jan 28, 2026

07:12
A Syngeneic Murine Model of Endometriosis using Naturally Cycling Mice
Published on: November 24, 2020
6.0K
Targeting Anthrax Toxin Receptor 2 Ameliorates Endometriosis Progression
Shih-Chieh Lin1,2,3, Hsiu-Chi Lee1, Ching-Ting Hsu3
1Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Theranostics
|February 28, 2019
Summary
Researchers identified Anthrax toxin receptor 2 (ANTXR2) as a key driver in endometriosis, promoting disease progression. Blocking ANTXR2 offers a promising therapeutic strategy for treating this prevalent gynecological condition.
Area of Science:
- Gynecology
- Molecular Biology
- Pathogenesis of Endometriosis
Background:
- Endometriosis is a common gynecological disease impacting women's quality of life and fertility.
- Current treatments for endometriosis are limited, necessitating research into underlying mechanisms and novel therapeutic targets.
Purpose of the Study:
- To identify druggable membrane receptors uniquely expressed in endometriotic cells.
- To investigate the role of identified targets in endometriosis pathogenesis.
- To evaluate therapeutic potential of targeting these receptors.
Main Methods:
- Bioinformatic analysis of public databases to identify potential drug targets.
- Analysis of human endometrial and endometriotic tissues and cells.
- Utilized mouse models to study molecular mechanisms and therapeutic outcomes.
Main Results:
- Anthrax toxin receptor 2 (ANTXR2) is upregulated in endometriosis, promoting cell adhesion, proliferation, and angiogenesis.
- Hypoxia drives ANTXR2 upregulation via epigenetic modifications (H3K27me3 and H3K4me3) at its promoter.
- ANTXR2 signaling activation increases YAP1 nuclear translocation, contributing to endometriosis pathology.
- Pharmacological inhibition of ANTXR2 prevents lesion development and regresses established lesions.
Conclusions:
- ANTXR2 is a novel therapeutic target for endometriosis.
- Targeting ANTXR2 presents a potential treatment strategy for endometriosis.
Related Concept Videos
Types of Toxins
3.6K
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
3.6K
Internal Receptors
74.6K
Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
74.6K
Tumor Progression
7.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.4K
Receptor-mediated Endocytosis
110.8K
Overview
110.8K
Enzyme-linked Receptors
86.5K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
86.5K
G-protein Coupled Receptors
131.9K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
131.9K

